Skip to main content
Top

2009 | OriginalPaper | Hoofdstuk

12 Medicijnen met een risico voor hart- en vaatziekten

Auteur : Dr. H.G.L.M. Grundmeijer

Gepubliceerd in: Praktische preventie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

In dit hoofdstuk worden de risico’s op hart- en vaatziekten van enkele veelgebruikte medicijnen behandeld.
Literatuur
1.
go back to reference Martin KA, Douglas PS. Risks and side effects associated with estrogen-progestin contraceptives. www.uptodate.com. Last literature review version 16.2, mei 2008. Martin KA, Douglas PS. Risks and side effects associated with estrogen-progestin contraceptives. www.​uptodate.​com. Last literature review version 16.2, mei 2008.
2.
go back to reference Rosenberg L, Palmer JR, Rao RS, Shapiro S. Low-dose oral contraceptive use and the risk of myocardial infarction. Arch Intern Med 2001;161(8):1065–70.CrossRefPubMed Rosenberg L, Palmer JR, Rao RS, Shapiro S. Low-dose oral contraceptive use and the risk of myocardial infarction. Arch Intern Med 2001;161(8):1065–70.CrossRefPubMed
3.
go back to reference Chasan-Taber L, Willett WC, Manson JE, et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996; 94(3):483–9.CrossRefPubMed Chasan-Taber L, Willett WC, Manson JE, et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996; 94(3):483–9.CrossRefPubMed
4.
go back to reference Douketis JD, Ginsberg JS, Holbrook A, et al. A re-evaluation of the risk for venous thrombo-embolism with the use of oral contraceptives and hormone replacement therapy. Arch Intern Med 1997;157(14):1522–30.CrossRefPubMed Douketis JD, Ginsberg JS, Holbrook A, et al. A re-evaluation of the risk for venous thrombo-embolism with the use of oral contraceptives and hormone replacement therapy. Arch Intern Med 1997;157(14):1522–30.CrossRefPubMed
6.
go back to reference Saag KG, Furs D. Major side effects of systemic glucocorticoids. www.update.com. Last literature review version 16.2, mei 2008. Saag KG, Furs D. Major side effects of systemic glucocorticoids. www.​update.​com. Last literature review version 16.2, mei 2008.
8.
go back to reference Feenstra J, Heerdink ER, Grobbee DE, Stricker BH. Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med 2002;162(3):265–70.CrossRefPubMed Feenstra J, Heerdink ER, Grobbee DE, Stricker BH. Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med 2002;162(3):265–70.CrossRefPubMed
9.
go back to reference Cohen HW, Gibson G, Alderman H. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000;108(1):2–8.CrossRefPubMed Cohen HW, Gibson G, Alderman H. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000;108(1):2–8.CrossRefPubMed
10.
go back to reference Ray WA, Meredith S, Thapa PB, et al. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004;75(3):234–41.CrossRefPubMed Ray WA, Meredith S, Thapa PB, et al. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004;75(3):234–41.CrossRefPubMed
Metagegevens
Titel
12 Medicijnen met een risico voor hart- en vaatziekten
Auteur
Dr. H.G.L.M. Grundmeijer
Copyright
2009
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-7249-2_12